
Isomorphic Labs lands $5 billion Series C funding for AI-designed drug clinical trials
Isomorphic Labs funding secured $5 billion in Series C funding to advance candidates toward clinical trials on 17 November 2026. The round brings together existing backers and new investors to expand the company's medicine pipeline.